Evidence map›Paper›PMID 38127772›Full record

ArticleJCO global oncology2023

Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities.

Chinmay T Jani, Harpreet Singh, Nour Abdallah, Christian Mouchati, Shreya Arora, Samuel Kareff, Justin Salciccioli, Carey C Thomson, Vamsidhar Velcheti

Abstract read
In one paragraph

Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chinmay T JaniSylvester Comprehensive Cancer Center at University of Miami, Miami, FL.ORCID 0000-0002-6917-5568
Harpreet SinghMDR Collaborative Group, London, United Kingdom.ORCID 0000-0002-8001-4191
Nour AbdallahMDR Collaborative Group, London, United Kingdom.
Christian MouchatiMDR Collaborative Group, London, United Kingdom.ORCID 0000-0002-3958-4125
Shreya AroraMDR Collaborative Group, London, United Kingdom.ORCID 0000-0003-2120-3563
Samuel KareffSylvester Comprehensive Cancer Center at University of Miami, Miami, FL.ORCID 0000-0001-7431-1221
Justin SalciccioliMDR Collaborative Group, London, United Kingdom.ORCID 0000-0001-8092-0883
Carey C ThomsonMount Auburn Hospital, Harvard Medical School, Cambridge, MA.
Vamsidhar VelchetiNew York University Langone Health, New York, NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLung cancer is the leading cause of cancer-related deaths in the United States. This study aims to analyze lung cancer incidence, mortality, and related statistics from 1990 to 2019, focusing on national- and state-level trends and exploring potential disparities between sexes.

methodsThe Global Burden of Disease database was used to extract tracheal, bronchus, and lung cancer mortality data from 1990 to 2019 for both males and females and across all states of the United States. Age-standardized incidence rates, age-standardized mortality rates, disability-adjusted life years (DALYs), and mortality-to-incidence indices (MIIs) were studied to assess for gender-based, geographic, and temporal disparities. Joinpoint regression analysis was performed to further evaluate trends.

resultsThe incidence of these cancers in the United States decreased between 1990 and 2019 by 23.35%, with a more significant decline in males (37.73%) than females (1.41%). Similarly, for mortality, a decrease was observed for both sexes combined (26.83%), but much more significantly for males (40.23%) than females (6.01%). The MIIs decreased overall, but there were variations across states. DALYs decreased for both sexes combined, with males experiencing a larger reduction, but an increase was noted in some states for females.

conclusionThis analysis reveals diverse trends pertaining to the incidence, mortality, and disability burden associated with lung cancer by sex and states in the United States, emphasizing the need for targeted interventions to reduce disparities. These findings contribute to our understanding of the current landscape of lung cancer and can inform future strategies for prevention, early detection, and management.

Indexed as

Lung NeoplasmsPersons with DisabilitiesFemaleHumansIncidenceMaleUnited States

Identifiers

PMID38127772
PMCPMC10752493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.